The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Auchincloss Thomas G since year 2005.
The trader's CIK number is 1377820.
At the time of the last reporting, Auchincloss Thomas G was the Director of Concert Pharmaceuticals, Inc. .
(stock ticker symbol CNCE).
See this page for all insider trading activities at Concert Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-03||CNCE||Concert Pharmaceuticals, Inc.||Buy||1,000||10.91||10,910|
|2018-11-15||CNCE||Concert Pharmaceuticals, Inc.||Buy||1,000||11.50||11,500|
|2018-11-14||CNCE||Concert Pharmaceuticals, Inc.||Buy||1,000||11.93||11,931|
|2007-06-28||MBLX||Yield10 Bioscience, Inc.||Sale||40,865||24.02||981,454|
|2007-06-28||MBLX||Yield10 Bioscience, Inc.||Option Ex||40,865||3.30||134,854|
|2006-11-10||MBLX||Yield10 Bioscience, Inc.||Buy||1,000||14.00||14,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Auchincloss Thomas G (Director of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.